Author: admin
VALNEVA
Declaration of shares and voting rights
June 30, 2024
__________________________________________________________________________________________
Company name: VALNEVA
Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)
Regulated market of Euronext Paris – Compartment B
Declaration date: July 4, 2024
| Number of shares composing the share capital of Valneva |
Total number of voting rights including suspended voting rights* | Description of the change | Date on which this change was recognized | Total number of voting rights excluding suspended voting rights** |
|
139,276,901 ordinary shares with a par value of €0.15 each |
157,644,580 | Transfer into bearer form of 750,000 shares with double voting rights
Double voting rights granted on 7,015 ordinary shares |
Between June 1 & June 30, 2024 |
157,520,258 |
___________________________
* Theoretical voting rights. This number is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.
** Net (or exercisable at a General Meeting) voting rights.
Attachment
Đề xuất
MagnesiumFreeze Sciatic Nerve Claims Evaluated: Consumer Research Report Examines Magnesium Niacinamide Relief Topical Cream Ingredients, NAD+ Science, and Sciatic Nerve Support Discussions
AIM ImmunoTech Announces Closing of its Rights Offering
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
Curaechoice and Health Benefit Alliance Partner to Deliver No-Cost Healthcare to 161,000 Members Across 42 States
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Autoliv announces appointment of new CFO